Dr.Kadalmani Krishnan

Dr. Kadalmani Krishnan is the Founder of Thrafford Lifescience, where he integrates science, strategy, and innovation to drive transformative healthcare solutions. He has led the development of an IP-driven point-of-care biomanufacturing platform, secured multi-source funding, and built global collaborations with leading institutions including AIIMS, THSTI, ICMR, MITVP, IBM, and others.

Previously, as General Manager – Strategy & Drug Development at Levim Lifetech, Dr. Krishnan spearheaded the creation of India’s first GLP-1 receptor agonist biosimilar, achieving near-total import substitution in diabetes care and earning the DBT Innovator Award. His strategic leadership has advanced multiple therapeutic programs, strengthened governance frameworks, and positioned Thrafford as a global innovation-driven enterprise.

A Cambridge Ph.D. and Harvard Medical School alumnus, Dr. Krishnan’s career spans India, Europe, and North America, bridging discovery and real-world impact across metabolic diseases, cancer diagnostics, and next-generation biotherapeutics. He has advised national and global bodies including ICMR, BIRAC, WHO and CDSCO, contributing to policy, innovation funding, and clinical frameworks.

As a TEDx speaker and mentor, he champions the convergence of AI, quantum computing, and advanced biologics in healthcare — advocating a “bench-to-society” mindset to inspire the next generation of scientists and innovators.